fda semaglutide warning news october 2025 U.S. | The FDA has approved a new higher dose (7.2 mg) of Wegovy ( semaglutide) injection, Wegovy HD, for weight loss and long-term weight FDA Approves Semaglutide (Wegovy) Pill

doi: 10.1002/ptr.6465 98 ChenSJiangHWuXFangJ

Among nearly 380,000 conscripts, isotretinoin use was not associated with clinically meaningful differences in adult height compared with individuals treated with other acne medications or those without acne

Life Extension is our runner-up for convenience because its a softgel

This may reduce discomfort during injection

GLP-1 Receptor Agonists May Reduce Rheumatoid Arthritis Activity and Cardiovascular Risk in People with Obesity Key Takeaways: GLP-1 receptor agonists were linked to reduced rheumatoid arthritis (RA) disease activity and improved cardiovascular risk factors in people with obesity or overweight